Contact
searchSearch
HMP Global

Health Care Policy and Legislation

conference coverage


Conference Coverage
MFN Pricing, IRA Negotiation, PBM Scrutiny, and 340B Remain Top Market Access Concerns
04/29/2026
Danielle Sposato
At Asembia 2026, market access leaders warned that sweeping policy shifts—from most favored nation (MFN) pricing and Inflation Reduction Act (IRA) negotiations to pharmacy benefit manager (PBM) and 340B reform—are reshaping global pricing...
At Asembia 2026, market access leaders warned that sweeping policy shifts—from most favored nation (MFN) pricing and Inflation Reduction Act (IRA) negotiations to pharmacy benefit manager (PBM) and 340B reform—are reshaping global pricing...
At Asembia 2026, market access...
04/29/2026
First Report Managed Care
Conference Coverage
IRA, MFN Pressure, and Coverage Volatility Are Reshaping Specialty Drug Access
04/28/2026
Danielle Sposato
At Asembia 2026, Dee Chaudhary, Principal, Commercial Strategy Consulting Life Sciences and Healthcare, Clarivate, outlined how the Inflation Reduction Act (IRA), renewed Most Favored Nation (MFN)-style pricing pressure, and broader coverage...
At Asembia 2026, Dee Chaudhary, Principal, Commercial Strategy Consulting Life Sciences and Healthcare, Clarivate, outlined how the Inflation Reduction Act (IRA), renewed Most Favored Nation (MFN)-style pricing pressure, and broader coverage...
At Asembia 2026, Dee Chaudhary,...
04/28/2026
First Report Managed Care
Conference Coverage
PBM Reform, Drug Pricing Policy, and Regulatory Uncertainty
04/28/2026
Danielle Sposato
As the 2026 midterm elections approach, the health policy landscape faces major uncertainty. This panel will explore how potential changes to congressional power-balance and state dynamics could shape key priorities like drug pricing,...
As the 2026 midterm elections approach, the health policy landscape faces major uncertainty. This panel will explore how potential changes to congressional power-balance and state dynamics could shape key priorities like drug pricing,...
As the 2026 midterm elections...
04/28/2026
First Report Managed Care
Conference Coverage
Federal Drug Pricing, Medicaid Policy, and PBM Reforms Shape 2026 Health Care Landscape
04/14/2026
Grace Taylor, MS, MA
A session at the annual AMCP conference unpacked the latest federal legislative and regulatory changes impacting drug pricing, Medicaid policy, and payer operations in a rapidly shifting environment.
A session at the annual AMCP conference unpacked the latest federal legislative and regulatory changes impacting drug pricing, Medicaid policy, and payer operations in a rapidly shifting environment.
A session at the annual AMCP...
04/14/2026
First Report Managed Care
Conference Coverage
H.R. 1, Medicaid Cuts, and Market Uncertainty: Federal Policy in Focus at AMCP Nexus 2025
10/28/2025
Juliet Gallagher
At AMCP Nexus 2025, policy experts Geni Tunstall, JD, and Adam Colborn, JD, provided an in-depth look at the political, legal, and regulatory developments shaping health care over the past year.
At AMCP Nexus 2025, policy experts Geni Tunstall, JD, and Adam Colborn, JD, provided an in-depth look at the political, legal, and regulatory developments shaping health care over the past year.
At AMCP Nexus 2025, policy...
10/28/2025
First Report Managed Care
Shackleton
Conference Coverage
The Advocacy Frontier: Navigating PBM Reform, Step Therapy, and More
06/25/2025
Explore how state policies on copay accumulators, PBMs, and step therapy are shaping the future of infusion care—and what you can do about it.
Explore how state policies on copay accumulators, PBMs, and step therapy are shaping the future of infusion care—and what you can do about it.
Explore how state policies on...
06/25/2025
First Report Managed Care
Conference Coverage
Aligning Stakeholders in Oncology’s Evolving Drug Distribution Landscape
05/28/2025
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACC
A guest expert from Asembia 2025 explores how reimagining limited drug distribution models in oncology can eliminate care fragmentation, enhance patient outcomes, and foster stronger collaboration among providers, pharmacies, payers, and...
A guest expert from Asembia 2025 explores how reimagining limited drug distribution models in oncology can eliminate care fragmentation, enhance patient outcomes, and foster stronger collaboration among providers, pharmacies, payers, and...
A guest expert from Asembia 2025...
05/28/2025
First Report Managed Care
Conference Coverage
Navigating MFP Implementation: Stakeholders Weigh IRA Challenges at Asembia 2025
05/22/2025
Juliet Gallagher
At Asembia 2025, industry experts from Cencora gathered to dissect the pressing challenges and evolving implementation framework of the Inflation Reduction Act’s (IRA) Maximum Fair Price (MFP) provision.
At Asembia 2025, industry experts from Cencora gathered to dissect the pressing challenges and evolving implementation framework of the Inflation Reduction Act’s (IRA) Maximum Fair Price (MFP) provision.
At Asembia 2025, industry...
05/22/2025
First Report Managed Care
Conference Coverage
What Payers and Manufacturers Need to Know About IRA Implementation
04/29/2025
Juliet Gallagher
In a packed session at Asembia 2025, Brian Corvino, lead partner at Deloitte Consulting, and Blasine Penkowski, former chief strategic customer officer at Johnson & Johnson, walked attendees through key lessons from early implementation of...
In a packed session at Asembia 2025, Brian Corvino, lead partner at Deloitte Consulting, and Blasine Penkowski, former chief strategic customer officer at Johnson & Johnson, walked attendees through key lessons from early implementation of...
In a packed session at Asembia...
04/29/2025
First Report Managed Care
Conference Coverage
The New Reality for Payers in a Shifting Health Care Environment
04/28/2025
Juliet Gallagher
At Asembia 2025, Luke Greenwalt, vice president at IQVIA, presented a sweeping overview of the evolving health care and pharmaceutical landscape, highlighting critical trends for payers as the industry enters a period of accelerated change.
At Asembia 2025, Luke Greenwalt, vice president at IQVIA, presented a sweeping overview of the evolving health care and pharmaceutical landscape, highlighting critical trends for payers as the industry enters a period of accelerated change.
At Asembia 2025, Luke Greenwalt,...
04/28/2025
First Report Managed Care

Pipeline Projections

PIPELINE PROJECTIONS
Emerging Therapies Reshaping Atopic Dermatitis Care
03/26/2026
Roy Moore
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly...
03/26/2026
First Report Managed Care
Pipe
Pipeline Projections
Emerging Migraine Treatments Challenge a Mature Market
11/20/2025
Roy Moore
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market...
11/20/2025
First Report Managed Care
Pipeline Projections
Pipeline Projections
Redefining Asthma Management With Emerging Anti-Inflammatories
10/01/2025
Roy Moore
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access...
10/01/2025
First Report Managed Care
Pipeline Projections
The Shift in MS Care as Biologics and BTK Inhibitors Advance
07/25/2025
Roy Moore
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline...
07/25/2025
First Report Managed Care
Pipeline Projections
How Biosimilars Are Shaping RA Treatment and Reimbursement Strategies
04/29/2025
Roy Moore
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline...
04/29/2025
First Report Managed Care

Behind the Bill

Behind the Bill
HHS Hits Reset on 340B Rebate Model After Court Setbacks
02/11/2026
Juliet Gallagher
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and...
02/11/2026
First Report Managed Care
Behind the Bill
Funding Package Extends Medicare Telehealth, Enacts PBM Reforms, and Updates Hospital Oversight
02/05/2026
Juliet Gallagher
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President...
02/05/2026
First Report Managed Care
Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use